StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultAug 7, 2026, 06:52 AM

Canopy Growth Q1 Net Loss $(14.6)M; Revenue $81.2M

AI Summary

Canopy Growth reported a net loss of $(14.6) million for the three months ended June 30, 2026, a significant improvement from $(44.9) million in the prior year. Net revenue increased to $81.2 million from $72.1 million year-over-year. The company also provided updates on its Canopy USA structure, including the deconsolidation of Canopy USA's financial results as of April 30, 2024, and disclosed that Acreage is in default under its Third ARCA, leading to a second forbearance agreement.

Key Highlights

  • Net loss improved to $(14.6) million for Q1 2027, compared to $(44.9) million in Q1 2026.
  • Net revenue increased to $81.2 million in Q1 2027, up from $72.1 million in Q1 2026.
  • Basic and diluted loss per share was $(0.03) for Q1 2027, compared to $(0.24) in Q1 2026.
  • Gross margin for Q1 2027 was $22.2 million, an increase from $18.0 million in Q1 2026.
  • Canopy USA's financial results were deconsolidated from Canopy Growth's financial statements as of April 30, 2024.
  • Acreage is in default under its Third ARCA, leading to a second forbearance agreement effective July 31, 2026.
  • Cash and cash equivalents decreased to $336.6 million at June 30, 2026, from $364.7 million at March 31, 2026.
  • Net cash used in operating activities increased to $(25.0) million in Q1 2027 from $(10.3) million in Q1 2026.